For millions of American women in their 40s and early 50s, perimenopause arrives as a collection of inconveniences: hot flashes, disrupted sleep, mood fluctuations, irregular cycles. These symptoms are frequently normalized by physicians and by culture as simply "part of aging" — temporary discomforts to be endured until menopause is complete.
But a study published in the Journal of the American Heart Association (JAHA) and released May 13, 2026 by the American Heart Association is making the case that this framing is dangerous — and that the perimenopause transition is not only a hormonal milestone but a critical cardiovascular inflection point, one that offers a "window of opportunity" that clinicians and patients are consistently missing.
The study analyzed health data from more than 9,200 women between the ages of 18 and 80 who had participated in the National Health and Nutrition Examination Survey between 2007 and 2020. Using the American Heart Association's Life's Essential 8 (LE8) framework — a standardized, evidence-based measure of cardiovascular health assessing blood pressure, cholesterol, blood sugar, weight, diet, physical activity, nicotine exposure, and sleep — the researchers scored each woman's cardiovascular health and compared outcomes by reproductive stage.
The finding was stark: perimenopausal women were twice as likely to have an overall low cardiovascular health score compared to women who were still having regular menstrual cycles. The low scores were primarily driven by two factors: significantly higher cholesterol levels and elevated blood sugar — both established, modifiable risk factors for heart disease.
What Happens to the Heart During Perimenopause — and Why the Window Matters
The biological explanation for perimenopause's cardiovascular impact is well-established but underappreciated in clinical practice. Before menopause, estrogen acts as a natural cardiovascular protector: it clears LDL cholesterol from the bloodstream, keeps blood vessel walls flexible and responsive, maintains insulin sensitivity, reduces inflammation, and supports healthy endothelial function. When estrogen levels begin to fluctuate and eventually decline during perimenopause, those protections erode quickly and silently.
As Honey Health reported in covering the study, standard laboratory testing often misses what is happening during this transition. A basic cholesterol panel will detect rising LDL, but other early cardiovascular risk changes, including shifts in apolipoprotein B (ApoB), early insulin resistance, arterial stiffness, and emerging hypertension, may not appear on routine annual bloodwork or may be attributed to aging rather than to the specific hormonal cascade of perimenopause.
The researchers explicitly framed this moment as a "window of opportunity" rather than only a warning. The argument is not that perimenopause is the onset of inevitable cardiovascular decline, but rather that the measurable deterioration in cardiovascular health scores that occurs at this stage is largely preventable, and that the transition period, precisely because the deterioration is just beginning, offers the best possible moment to intervene before damage accumulates.
Medical News Today reporting on the study noted that cardiovascular health declined progressively across all three reproductive stages studied — premenopause, perimenopause, and postmenopause — with diet scores consistently among the lowest across all groups. Perimenopausal women showed the steepest single-stage decline, making this the most critical moment for clinician engagement.
| Life's Essential 8 Metric | Effect During Perimenopause |
| Blood pressure | Rises as estrogen protection declines |
| Cholesterol (primary driver) | Elevated — key finding in study |
| Blood sugar (primary driver) | Elevated — key finding in study |
| Weight / BMI | Metabolic rate declines; adipose redistribution toward abdomen |
| Diet | Consistently lowest scores across all women in study |
| Physical activity | Often declines during perimenopause due to fatigue and sleep disruption |
| Nicotine exposure | Pre-existing risk factor for affected women |
| Sleep health | Disrupted by hormonal fluctuations; compounds cardiovascular risk |
What the Study Means for Clinicians and Women Right Now
The study's lead author, whose team called for immediate changes in clinical practice, said: "We hope these findings encourage clinicians to begin screening for high blood pressure, cholesterol and type 2 diabetes earlier in the perimenopausal transition, leading to earlier diagnosis, prevention and intervention at a critical time in women's lives." The researchers noted their next step is to follow women over multiple years to track hormone levels alongside heart health markers, which will help clarify the long-term impact of perimenopause and how specific lifestyle changes translate to reduced risk.
For women currently in perimenopause, typically beginning in the mid-to-late 40s and lasting an average of four years before menopause is confirmed, the public health message is clear: cardiovascular symptoms and metabolic changes during this period are not cosmetic inconveniences. They are early warning signals that should trigger a cardiovascular health conversation with a physician.
Practical steps supported by the LE8 framework include: requesting a full lipid panel with ApoB if available, having blood pressure checked at every appointment, and a hemoglobin A1c or fasting glucose test to catch early insulin resistance. Aerobic exercise of 150 minutes or more per week, strength training twice weekly, prioritizing sleep quality, and adopting a Mediterranean or DASH dietary pattern are all evidence-based interventions that directly address the risk factors the study identified as most impaired during perimenopause. Cardiovascular disease accounts for approximately 30% of all deaths in women globally, according to the World Heart Federation, making prevention during this period one of the highest-impact opportunities in women's health.
Frequently Asked Questions
What did the perimenopause heart disease study find?
A study published in the Journal of the American Heart Association on May 13, 2026, analyzing health data from more than 9,200 women, found that perimenopausal women were twice as likely to have a low cardiovascular health score compared to premenopausal women. The biggest drivers were elevated cholesterol and blood sugar levels.
Why does perimenopause affect heart health?
Before menopause, estrogen helps clear LDL cholesterol from the blood, keeps blood vessels healthy, maintains insulin sensitivity, and regulates inflammation. When estrogen fluctuates and declines during perimenopause, those protections erode rapidly. Cholesterol, blood pressure, and blood sugar can all shift significantly in a matter of months, often without obvious symptoms.
What is the "window of opportunity" the researchers described?
Researchers believe that because the cardiovascular health decline during perimenopause is just beginning and is largely driven by modifiable risk factors (cholesterol, blood sugar, diet, activity), this is the optimal window for lifestyle intervention and clinical screening. Acting during perimenopause, before postmenopausal cardiovascular disease accelerates, can have lasting protective effects.
What should women in perimenopause ask their doctors about?
Request a full lipid panel with LDL and, if possible, ApoB. Ask for blood pressure monitoring, fasting glucose or hemoglobin A1c, and a full cardiovascular risk assessment using tools like AHA's Life's Essential 8. Discuss any symptoms of sleep disruption, which also independently affects cardiovascular health. Ask about both lifestyle interventions and whether hormone therapy is appropriate for your specific risk profile.
What lifestyle changes matter most during perimenopause for heart health?
The American Heart Association's Life's Essential 8 framework identifies diet quality, physical activity (at least 150 minutes of aerobic exercise weekly), blood pressure management, cholesterol control, blood sugar regulation, healthy weight, adequate sleep, and avoiding tobacco as the key modifiable factors. Diet quality was consistently the lowest-scoring area across all women in the study.
